In a follow-up study, Bar et al. concluded that high doses of AAV9-Tert could act on the bone marrow in two different mouse models of short telomere-induced aplastic anemia (Trf1- and Tert-deficient mice). Here, TERT is linked to idiopathic aplastic anemia.